Shares of Adalta Ltd (ASX:1AD) fell 18.8% during mid-day trading on Tuesday . The company traded as low as A$0.12 ($0.09) and last traded at A$0.13 ($0.09), 1,400,751 shares were traded during trading. The stock had previously closed at A$0.16 ($0.11).
The company has a 50-day simple moving average of A$0.18. The firm has a market capitalization of $18.47 million and a price-to-earnings ratio of -3.61.
Adalta Company Profile (ASX:1AD)
AdAlta Limited, a drug discovery and development company, develops protein therapeutics. The company focuses on developing its lead i-body drug candidate, AD-114, for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. It has a collaborative partnership with Excellerate Bioscience to advance the development of its i-body pipeline.
Further Reading: Bond
Receive News & Ratings for Adalta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adalta and related companies with MarketBeat.com's FREE daily email newsletter.